{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:52:50Z","timestamp":1784055170756,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-34300"],"award-info":[{"award-number":["HL-34300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.yexcr.2016.11.016","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T02:47:44Z","timestamp":1479696464000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Caloric restriction ameliorates cardiomyopathy in animal model of diabetes"],"prefix":"10.1016","volume":"350","author":[{"given":"Keren","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Laniado-Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Gurfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Aravot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hochhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yexcr.2016.11.016_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00003495-200363100-00002","article-title":"Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?","volume":"63","author":"Scheen","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","article-title":"Oxidative stress and myocardial injury in the diabetic heart","volume":"229","author":"Ansley","year":"2013","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.yexcr.2016.11.016_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/HJH.0b013e3282fe1d3d","article-title":"Development of heart failure in recent hypertension trials","volume":"26","author":"Tocci","year":"2008","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.yexcr.2016.11.016_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","article-title":"Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study","volume":"30","author":"Du","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexcr.2016.11.016_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2015.10.119","article-title":"Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy","volume":"203","author":"Frustaci","year":"2016","journal-title":"Int J. Cardiol."},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail Rev."},{"issue":"Suppl. 5","key":"10.1016\/j.yexcr.2016.11.016_bib7","first-page":"S19","article-title":"Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders","volume":"9","author":"Fyhrquist","year":"1995","journal-title":"J. Hum. Hypertens."},{"issue":"6","key":"10.1016\/j.yexcr.2016.11.016_bib8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.HYP.0000128620.57061.67","article-title":"Profibrotic effects of angiotensin II in the heart: a matter of mediators","volume":"43","author":"Diez","year":"2004","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.yexcr.2016.11.016_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10557-010-6274-4","article-title":"Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes","volume":"25","author":"Hung","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6566","key":"10.1016\/j.yexcr.2016.11.016_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/379632a0","article-title":"Abnormal splicing of the leptin receptor in diabetic mice","volume":"379","author":"Lee","year":"1996","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.yexcr.2016.11.016_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.ijo.0803024","article-title":"Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: the finnish diabetes prevention study","volume":"29","author":"Salopuro","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.yexcr.2016.11.016_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.yexcr.2016.11.016_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCULATIONAHA.106.650671","article-title":"Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice","volume":"115","author":"Gao","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.humimm.2008.12.003","article-title":"Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes","volume":"70","author":"Buraczynska","year":"2009","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2016.11.016_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10753-012-9541-7","article-title":"Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus","volume":"36","author":"Jiang","year":"2013","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.yexcr.2016.11.016_bib18","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.yexcr.2016.11.016_bib19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1101\/gad.1550907","article-title":"Mechanisms of obesity-associated insulin resistance: many choices on the menu","volume":"21","author":"Qatanani","year":"2007","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.yexcr.2016.11.016_bib20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2016.11.016_bib21","doi-asserted-by":"crossref","unstructured":"O. Avlas, et al., Silencing cardiomyocyte TLR4 reduces injury following hypoxia. Exp Cell Res. 2016.","DOI":"10.1016\/j.yexcr.2016.07.020"},{"issue":"6","key":"10.1016\/j.yexcr.2016.11.016_bib22","doi-asserted-by":"crossref","first-page":"e0120175","DOI":"10.1371\/journal.pone.0120175","article-title":"TLR4 expression is associated with left ventricular dysfunction in patients undergoing coronary artery bypass surgery","volume":"10","author":"Avlas","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00207454.2014.1002609","article-title":"Relative neuroprotective effects hyperbaric oxygen treatment and TLR4 knockout in a mouse model of temporary middle cerebral artery occlusion","volume":"126","author":"Pushkov","year":"2016","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib24","first-page":"481","article-title":"Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy","volume":"7","author":"Ma","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.yexcr.2016.11.016_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"Fessler","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"issue":"11","key":"10.1016\/j.yexcr.2016.11.016_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity","volume":"100","author":"Kim","year":"2007","journal-title":"Circ. Res"},{"issue":"6","key":"10.1016\/j.yexcr.2016.11.016_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cmet.2006.11.008","article-title":"Fat uses a TOLL-road to connect inflammation and diabetes","volume":"4","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.yexcr.2016.11.016_bib28","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.yexcr.2016.11.016_bib29","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/db05-1574","article-title":"Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase","volume":"55","author":"Wang","year":"2006","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.yexcr.2016.11.016_bib30","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112655","article-title":"Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) in a mouse liver gene expression compendium","volume":"10","author":"Oshida","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yexcr.2016.11.016_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.29.02.06.dc05-1484","article-title":"Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects","volume":"29","author":"Mori","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.yexcr.2016.11.016_bib34","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"Stefan","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.yexcr.2016.11.016_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med"},{"key":"10.1016\/j.yexcr.2016.11.016_bib36","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1038\/ncomms4557","article-title":"Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys","volume":"5","author":"Colman","year":"2014","journal-title":"Nat. Commun."},{"issue":"7415","key":"10.1016\/j.yexcr.2016.11.016_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature11432","article-title":"Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study","volume":"489","author":"Mattison","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexcr.2016.11.016_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mam.2011.07.001","article-title":"Caloric restriction","volume":"32","author":"Speakman","year":"2011","journal-title":"Mol. Asp. Med"},{"issue":"12","key":"10.1016\/j.yexcr.2016.11.016_bib39","doi-asserted-by":"crossref","first-page":"e0144593","DOI":"10.1371\/journal.pone.0144593","article-title":"Long-lived alphaMUPA mice show attenuation of cardiac aging and Leptin-dependent cardioprotection","volume":"10","author":"Levy","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000341432","article-title":"Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4","volume":"30","author":"Ben-Ari","year":"2012","journal-title":"Cell Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.yexcr.2016.11.016_bib41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bcp.2013.03.014","article-title":"An ultra-low dose of tetrahydrocannabinol provides cardioprotection","volume":"85","author":"Waldman","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexcr.2016.11.016_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin."},{"key":"10.1016\/j.yexcr.2016.11.016_bib43","doi-asserted-by":"crossref","DOI":"10.3402\/ijch.v72i0.21190","article-title":"Preliminary analysis of immune activation in early onset type 2 diabetes","volume":"72","author":"Rempel","year":"2013","journal-title":"Int. J. Circumpolar Health"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.107.170225","article-title":"Toll-like receptor signaling: defensive or offensive for the heart?","volume":"102","author":"Hori","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2016.11.016_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.062","article-title":"Innate immunity and cardiomyocytes in ischemic heart disease","volume":"100","author":"Lin","year":"2014","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2016.11.016_bib46","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.CCM.0000256723.37586.A2","article-title":"Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction","volume":"35","author":"Zhu","year":"2007","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.yexcr.2016.11.016_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.exger.2007.03.009","article-title":"Caloric restriction in humans","volume":"42","author":"Holloszy","year":"2007","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ajh.2007.50","article-title":"Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models","volume":"21","author":"Tomono","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"1\u20132","key":"10.1016\/j.yexcr.2016.11.016_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2012.03.005","article-title":"Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction","volume":"378","author":"Jing","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.yexcr.2016.11.016_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cjca.2012.01.013","article-title":"Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis","volume":"28","author":"Issan","year":"2012","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"10.1016\/j.yexcr.2016.11.016_bib51","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.yexcr.2016.11.016_bib52","doi-asserted-by":"crossref","first-page":"d169","DOI":"10.2741\/A272","article-title":"Free fatty acids (FFA), a link between obesity and insulin resistance","volume":"3","author":"Boden","year":"1998","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.yexcr.2016.11.016_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.numecd.2016.03.012","article-title":"Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes","volume":"26","author":"Wolf","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.yexcr.2016.11.016_bib54","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/dc12-1591","article-title":"Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study","volume":"36","author":"Jensen","year":"2013","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.yexcr.2016.11.016_bib55","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2016.11.016_bib56","doi-asserted-by":"crossref","first-page":"e0130658","DOI":"10.1371\/journal.pone.0130658","article-title":"Cardioprotective signature of short-term caloric restriction","volume":"10","author":"Noyan","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yexcr.2016.11.016_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2016.11.016_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2015.04.814","article-title":"Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome","volume":"241","author":"Jialal","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271630386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271630386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T10:27:40Z","timestamp":1536229660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448271630386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S001448271630386X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.11.016","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caloric restriction ameliorates cardiomyopathy in animal model of diabetes","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}